2015 BPD Header

Cambridge Healthtech Institute’s 5th Annual
Bioproduction: Scale, Bioreactors & Disposables
Making It Work
August 5-6, 2015
Part of CHI's 7th Annual The Bioprocessing Summit

August 3-7, 2015 | Westin Copley Place Hotel | Boston, Massachusetts

Preliminary Agenda 

This meeting will look at the bigger picture of bioprocessing while exploring the details of optimizing processes, both from a practical and an engineering viewpoint, particularly bioreactor engineering. Creating models for scaling down and scaling up, as well as disposables, will also be discussed, as will monitoring and analyzing processes in order to reach optimal conditions and productivity. Examining how bioreactors process cells will be addressed, from small operational details to large-scale bioproduction.


Planning for the Future: Manufacturing Capacity Versus Demand Uncertainty

Peter F. Moesta, Ph.D., Senior Vice President, Biologics Manufacturing & Process Development, Bristol Myers Squibb Co.

Fc-Fusions versus mABs: Opportunities and Limits of Platform Processes

Stefan Schmidt, Ph.D., M.B.A., Vice President, GMP Operations, Rentschler Biotechnologie GmbH

Challenges in N-1 Perfusion Process Optimization

Weimin Lin, Ph.D., Process Development Scientist, Biogen Idec, Inc.


Points to Consider when Scaling Up Raw Materials in Your Manufacturing Process

David Kolwyck, M.B.A., Director, Manufacturing Science - Raw Materials, Biogen Idec

Technology Transfer when Scaling Up Processes

Jayant Aphale, Ph.D., M.B.A., Senior Vice President, Technical Operations, Sarepta Therapeutics

Scale-Down Models for Upstream Cell Culture Processes

Eric J. Wallenstein, Ph.D., Associate Principal Scientist, Biologics Manufacturing Science & Commercialization, Merck & Co., Inc. – tentative

Overcoming Scale-Down Model Development Challenges for MAb Production

Gayle E. Derfus, Ph.D., Senior Research Scientist I, Gilead Sciences

Talk Title to be Announced

Akash Joshi, MSc., Scientist, Boehringer Ingelheim


Scale-Down Model Development in Single-Use Minibioreactors

Hao Chen, Ph.D., Director, Upstream Process Development, BioProcess R&D, Merck Research Laboratories


The Effect of Microspargers on Product Quality Variability in Large-Scale Perfusion Bioreactors

Nirel Rillera, Research Associate, BioMarin Pharmaceuticals, Inc.



For more details on the conference,
please contact:

Mary Ruberry
Senior Conference Director
Phone: 781-972-5421
Email: mruberry@healthtech.com 

For exhibit & sponsorship opportunities, please contact: 

Companies A-K:
Elizabeth Lemelin
Business Development Manager
Phone: 781-972-1342
Email: elemelin@healthtech.com 

Companies L-Z:
Sherry Johnson
Business Development Manager
Phone: 781-972-1359
Email: sjohnson@healthtech.com